Augmented Renal Vancomycin Clearance in Cancer Patients: A Case Report and Review of the Literature

被引:11
|
作者
Curth, Harald-Morten [1 ]
Pelc, Agnes [1 ]
Kuetting, Fabian [1 ]
Steffen, Hans-Michael [1 ]
机构
[1] Univ Hosp Cologne, Dept Gastroenterol & Hepatol, D-50937 Cologne, Germany
关键词
Palliative care; Inflammation; Pharmacokinetics; Dose-response relationship; drug; HEMATOLOGICAL MALIGNANCIES; PHARMACOKINETICS;
D O I
10.1159/000377652
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Bacterial infections are a major cause of morbidity and mortality in cancer patients. Particularly diagnostic and therapeutic procedures (e.g. central venous catheters, paracentesis) increase the risk of infections in this immunocompromised patient population. In the past, antibiotic therapy was empirically initiated in these patients, guided by treatment regimens designed for patients without malignancy; however, the hyperdynamic circulation in systemic inflammatory response syndrome, as well as the presence of malignancy itself, may have a crucial impact on treatment success. Case Report: Here, we report the case of a 55-year-old patient with advanced pancreatic cancer and Staphylococcus epidermidis bacteremia who, due to increased renal vancomycin clearance, required treatment with high doses of vancomycin in order to reach therapeutic trough levels. Conclusion: Oncological status can be a cofactor of altered pharmacokinetics in terms of a paraneoplastic syndrome. With the help of this case report we want to call attention to this clinically significant phenomenon with its inherent risk of inefficient antibiotic treatment.
引用
收藏
页码:182 / 184
页数:3
相关论文
共 50 条
  • [31] Augmented Renal Clearance in Patients With Febrile Neutropenia is Associated With Increased Risk for Subtherapeutic Concentrations of Vancomycin
    Hirai, Keita
    Ishii, Hidetoshi
    Shimoshikiryo, Takayuki
    Shimomura, Tatsuki
    Tsuji, Daiki
    Inoue, Kazuyuki
    Kadoiri, Toshihiko
    Itoh, Kunihiko
    [J]. THERAPEUTIC DRUG MONITORING, 2016, 38 (06) : 706 - 710
  • [32] VANCOMYCIN PHARMACOKINETICS IN PEDIATRIC PATIENTS WITH FEBRILE NEUTROPENIA (FN): EFFECT OF AUGMENTED RENAL CLEARANCE (ARC).
    Shimamoto, Y.
    Mizuno, T.
    Verstegen, R.
    Allen, U.
    Ito, S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S105 - S105
  • [33] An individualized administration model of vancomycin in elderly patients with sepsis and factors influencing augmented renal clearance
    Zhou, Qingtao
    Zhao, Feifan
    Wang, Meng
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (02) : 447 - 453
  • [34] Augmented Renal Clearance of Vancomycin and Levetiracetam in a Traumatic Brain Injury Patient
    Cook, Aaron M.
    Arora, Shaily
    Davis, Justin
    Pittman, Thomas
    [J]. NEUROCRITICAL CARE, 2013, 19 (02) : 210 - 214
  • [35] Augmented Renal Clearance of Vancomycin and Levetiracetam in a Traumatic Brain Injury Patient
    Aaron M. Cook
    Shaily Arora
    Justin Davis
    Thomas Pittman
    [J]. Neurocritical Care, 2013, 19 : 210 - 214
  • [36] Scoping review of augmented renal clearance in critically ill pediatric patients
    Rhoney, Denise H.
    Metzger, Samuel A.
    Neslon, Nicholas R.
    [J]. PHARMACOTHERAPY, 2021, 41 (10): : 851 - 863
  • [37] A RAPID REVIEW OF AUGMENTED RENAL CLEARANCE IN PATIENTS WITH COVID-19
    Nelson, Nicholas
    Brooks, Ashley
    Rhoney, Denise
    [J]. CRITICAL CARE MEDICINE, 2022, 50 (01) : 110 - 110
  • [38] Agranulocytosis Induced by Vancomycin. Case Report and Literature Review
    di Fonzo, Horacio
    Gutsh, Melina Villegas
    Castroagudin, Augusto
    Cabrera, Maria Victoria
    Mazzei, Mariano E.
    Rueda, Dario
    [J]. AMERICAN JOURNAL OF CASE REPORTS, 2018, 19 : 1053 - 1056
  • [39] Vancomycin-associated thrombocytopenia: Case report and review of the literature
    Kuruppu, JC
    Le, TP
    Tuazon, CU
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1999, 60 (03) : 249 - 250
  • [40] Spontaneous regression of metastatic renal cancer - Case report and literature review
    Lokich, J
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (04): : 416 - 418